Urba WJ - Search Results

1

Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.

Clark JI, Atkins MB, Urba WJ, Creech S, Figlin RA, Dutcher JP, Flaherty L, Sosman JA, Logan TF, White R, Weiss GR, Redman BG, Tretter CP, McDermott D, Smith JW, Gordon MS, Margolin KA. Clark JI, et al. Among authors: urba wj. J Clin Oncol. 2003 Aug 15;21(16):3133-40. doi: 10.1200/JCO.2003.02.014. Epub 2003 Jun 16. J Clin Oncol. 2003. PMID: 12810695 Clinical Trial.

2

Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study.

Sznol M, Steis RG, Smith JW 2nd, Janik JE, Sharfman WH, Urba WJ, Fenton RG, Creekmore SP, Beveridge J, Longo DL. Sznol M, et al. Among authors: urba wj. Online J Curr Clin Trials. 1992 Jul 1;Doc No 9:[3841 words; 32 paragraphs]. Online J Curr Clin Trials. 1992. PMID: 1343617 Clinical Trial.

3

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.

Smith JW 2nd, Urba WJ, Curti BD, Elwood LJ, Steis RG, Janik JE, Sharfman WH, Miller LL, Fenton RG, Conlon KC, et al. Smith JW 2nd, et al. Among authors: urba wj. J Clin Oncol. 1992 Jul;10(7):1141-52. doi: 10.1200/JCO.1992.10.7.1141. J Clin Oncol. 1992. PMID: 1607919 Clinical Trial.

4

Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.

Sznol M, Clark JW, Smith JW 2nd, Steis RG, Urba WJ, Rubinstein LV, VanderMolen LA, Janik J, Sharfman WH, Fenton RG, et al. Sznol M, et al. Among authors: urba wj. J Natl Cancer Inst. 1992 Jun 17;84(12):929-37. doi: 10.1093/jnci/84.12.929. J Natl Cancer Inst. 1992. PMID: 1629914

5

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

Longo DL, Duffey PL, Young RC, Hubbard SM, Ihde DC, Glatstein E, Phares JC, Jaffe ES, Urba WJ, DeVita VT Jr. Longo DL, et al. Among authors: urba wj. J Clin Oncol. 1992 Feb;10(2):210-8. doi: 10.1200/JCO.1992.10.2.210. J Clin Oncol. 1992. PMID: 1732422

6

Phase I evaluation of recombinant tumor necrosis factor given in combination with recombinant interferon-gamma.

Smith JW 2nd, Urba WJ, Clark JW, Longo DL, Farrell M, Creekmore SP, Conlon KC, Jaffe H, Steis RG. Smith JW 2nd, et al. Among authors: urba wj. J Immunother (1991). 1991 Oct;10(5):355-62. doi: 10.1097/00002371-199110000-00007. J Immunother (1991). 1991. PMID: 1790143 Clinical Trial.

7

The in vivo immunomodulatory effects of recombinant interferon gamma plus recombinant tumor necrosis factor-alfa.

Urba WJ, Kopp WC, Clark JW, Smith JW 2nd, Steis RG, Huber C, Coggin D, Longo DL. Urba WJ, et al. J Clin Oncol. 1991 Oct;9(10):1831-9. doi: 10.1200/JCO.1991.9.10.1831. J Clin Oncol. 1991. PMID: 1919633 Clinical Trial.

8

Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.

Longo DL, Glatstein E, Duffey PL, Young RC, Hubbard SM, Urba WJ, Wesley MN, Raubitschek A, Jaffe ES, Wiernik PH, et al. Longo DL, et al. Among authors: urba wj. J Clin Oncol. 1991 Jun;9(6):906-17. doi: 10.1200/JCO.1991.9.6.906. J Clin Oncol. 1991. PMID: 2033427 Clinical Trial.

9

Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity.

Steis RG, Urba WJ, VanderMolen LA, Bookman MA, Smith JW 2nd, Clark JW, Miller RL, Crum ED, Beckner SK, McKnight JE, et al. Steis RG, et al. Among authors: urba wj. J Clin Oncol. 1990 Oct;8(10):1618-29. doi: 10.1200/JCO.1990.8.10.1618. J Clin Oncol. 1990. PMID: 2213099

10

Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen.

Clark JW, Smith JW 2nd, Steis RG, Urba WJ, Crum E, Miller R, McKnight J, Beman J, Stevenson HC, Creekmore S, et al. Clark JW, et al. Among authors: urba wj. Cancer Res. 1990 Nov 15;50(22):7343-50. Cancer Res. 1990. PMID: 2224862 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters